Cargando…
Prognostic factors in breast cancer patients evaluated by positron-emission tomography/computed tomography before neoadjuvant chemotherapy
Neoadjuvant chemotherapy (NAC) is a significant modality in breast cancer therapy. We sought to characterize prognostic factors in patients scheduled for NAC who had a pretreatment positron-emission tomography paired with diagnostic quality contrast-enhanced computed tomography (CT) (positron-emissi...
Autores principales: | Farrugia, Mark K., Wen, Sinjen, Jacobson, Geraldine M., Salkeni, Mohamad Adham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216743/ https://www.ncbi.nlm.nih.gov/pubmed/30505226 http://dx.doi.org/10.4103/wjnm.WJNM_84_17 |
Ejemplares similares
-
Efficiency of fluorodeoxyglucose positron emission tomography/computed tomography to predict prognosis in breast cancer patients received neoadjuvant chemotherapy
por: Ishiba, Toshiyuki, et al.
Publicado: (2015) -
The effect of positron emission tomography/computed tomography in axillary surgery approach after neoadjuvant treatment in breast cancer
por: Memişoğlu, Ecem, et al.
Publicado: (2023) -
Comparison of (18)F-fluorothymidine Positron Emission Tomography/Computed Tomography and (18)F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Breast Cancer
por: Mori, Mio, et al.
Publicado: (2022) -
Prognostic Value of Axillary Lymph Node Texture Parameters Measured by Pretreatment (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Locally Advanced Breast Cancer with Neoadjuvant Chemotherapy
por: Hwang, Jae Pil, et al.
Publicado: (2022) -
Role for Positron Emission Tomography-Computed Tomography in Melioidosis
por: Ayub, Irfan Ismail, et al.
Publicado: (2021)